The hidden reason cancer immunotherapy often fails

Cancer immunotherapy has reshaped cancer treatment by training the body’s immune system to recognize and attack tumors. Drugs known as immune checkpoint inhibitors, which target the PD-1/PD-L1 pathway, have led to long-lasting responses in some patients and fueled optimism about durable cancer…

Click here to view the original article.